Early-onset neonatal group B streptococcal infection; 2002 guidelines for prevention

Journal of Midwifery and Women's Health

Volumn 47, Issue 6, 2002, Pages 435-446

  Jolivet, R Rima ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATION; CHILDBIRTH; CLINICAL PRACTICE; DISEASE CARRIER; DISEASE CONTROL; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH SERVICE; HEALTH SURVEY; HUMAN; NEWBORN; NEWBORN INFECTION; NEWBORN SCREENING; OBSTETRICS; PENICILLIN ALLERGY; PRACTICE GUIDELINE; PREMATURE LABOR; REVIEW; RISK ASSESSMENT; STREPTOCOCCUS AGALACTIAE; TOCOLYSIS;

EID: 0037069529     PISSN: 15269523     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-9523(02)00348-3     Document Type: Article

References (60)

1. Regan JA, Klebanoff MA, Nugent RP. The epidemiology of group B streptococcal colonization in pregnancy: vaginal infections and prematurity study group. Obstet Gynecol 1991;77:604-10.
2. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996; 45(No. RR-7):1-24.
3. Schuchat A. Group B streptococcal disease in newborns: a global perspective on prevention. Biomed Pharmacother 1995;49:19-25.
4. Baker CJ, Barrett FF, Gordon RC, Yow MD. Suppurative meningitis due to streptococci of Lancefield group B: a study of 33. J Pediatr 1973;82:724-29.
5. Franciosi RA, Knostman JD, Zimmerman RA. Group B streptococcal neonatal and infant infections. J Pediatr 1973;82:707-18.
6. McCracken GH. Group B streptococci: the new challenge in neonatal infections. J Pediatr 1973;82:703-6.
7. Centers for Disease Control and Prevention. Early-onset group B streptococcal disease, United States, 1998 1999. MMWR 2000;49(No. 35):793-796.
8. Landon MB, Harger J, McNellis D, Mercer B, Thom EA. Prevention of neonatal group B streptococcal infection. Obstet Gynecol 1994;84: 460-2.
9. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR 2002; 51(No. RR-11)1-23.
10. Committee on Obstetric Practice of the American College of Obstetricians and Gynecologists. Prevention of early-onset group B streptococcal disease in newborns. Washington (DC): American College of Obstetricians and Gynecologists, 1996.
11. Committee on Infectious Diseases/Committee on Fetus and Newborn of the American Academy of Pediatrics. Revised guidelines for prevention of early-onset group B streptococcal (GBS) disease. Pediatrics 1997;99:489-96.
12. Benitz WE, Gould JB, Druzin ML. Preventing early-onset group B streptococcal sepsis: strategy development using decision analysis. Pediatrics 1999;103(6):e76.
13. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.
14. Committee on Infectious Diseases/Committee on Fetus and Newborn of the American Academy of Pediatrics. Guidelines for prevention of group B streptococcal (GBS) infections by chemoprophylaxis. Pediatrics 1992;90:775-8.
15. American College of Obstetricians and Gynecologists. Group B streptococcal infections in pregnancy. ACOG Technical Bulletin No. 170 1993;42:55-9.
16. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveillance Summary 1992;41:25-32.
17. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz, LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15-20.
18. Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by clinical literature review. Pediatrics 1999;103(6):e78.
19. Baker CJ, Edwards MS. Group B streptococcal infections. In: Remington J, Klein JO, editors. Infectious diseases of the fetus and newborn infant. Philadelphia (PA): WB Saunders, 1990:742-811.
20. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, et al, for the Active Bacterial Core Surveillance Team. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233-9.
21. Schuchat A, Oxtoby M, Cochi S, Sikes RK, Plikaytis BD. Population based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis 1990;162:672-7.
22. Dillon HC, Khare S, Gray BM. Group B streptococcal carriage and disease: a 6 year prospective study. J Pediatr 1987;110:31-6.
23. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D, for the Methods Word Group, third U.S. Preventive Services Task Force. Current methods of the U.S. Preventive Services Task Force: a review of the process. Am J Prev Med 2001;20(3S):21-35.
24. Lin FYC, Brenner RA, Johnson YR, Azimi PH, Phillips JB, Regan JA, et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol 2001;184:1204-10.
25. de Cueto M, Sanchez M, Sampedro A, Miranda J, Herruzo A, Rosa-Fraile M. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol 1998; 91:112-4.
26. Ramus RM, McIntire DD, Wendel GD Jr. Antibiotic chemoprophylaxis for group B streptococcus is not necessary with elective cesarean section at term. Am J Obstet Gynecol 1999;180:S85.
27. Hager WD, Schuchat A, Gibbs R, Sweet R, Mead P, Larsen JW. Prevention of perinatal group B streptococcal infection: current controversies. Obstet Gynecol 2000;96:141-5.
28. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002;347:240-7.
29. Andrews JI, Diekema DJ, Hunter SK, Rhomberg PR, Pfaller MA, Jones RN, et al. Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping resulting from SENTRY centers in the Western hemisphere. Am J Obstet Gynecol 2000;183: 859-62.
30. Fernandez M, Hickman ME, Baker CJ. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother 1998;42: 1517-9.
31. Lin FYC, Azimi PH, Weisman LE, Phillips JB 3rd, Regan JA, Clanc P, et al. Antibiotic susceptibility profiles for group B streptococci isolates from neonates, 1995-1998. Clin Infect Dis 2000;31:76-9.
32. Bland HL, Vermillion ST, Soper DE, Austin M. Antibiotic resistance patterns of group B streptococci in late third-trimester rectovaginal cultures. Am J Obstet Gynecol 2001;184:1125-6.
33. Salkind AR. Is this patient allergic to penicillin? An evidence-based analysis of the likelihood of penicillin allergy. J Am Med Assoc 2001;285: 2498-2505.
34. Solensky R, Earl HS, Grunchall RS. Clinica approach to penicillin-allergic patients: a survey. Ann Allergy Asthma Immunol 2000; 84:329-33.
35. Bromberger P, Lawrence JM, Braun D, Saunders B, Contreras R, Pettiti DB. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics 2000;106:224-50.
36. Persson K, Christensen KK, Christensen P, Forsgren A, Jorgensen C, Persson P. Asymptomatic bacteriuria during pregnancy with special reference to group B streptococci. Scand J Infect Di 1985;17: 195-9.
37. Wood EG, Dillon HC. A prospective study of group B streptococcal bacteriuria in pregnancy. Am J Obstet Gynecol 1981;140:515-20.
38. Christensen KK, Dahlander K, Linden V, Svenningsen N, Christensen P. Obstetrical care in future pregnancies after fetal loss in group B septicemia: a prevention program based on bacteriological and immunological follow-up. Eur J Obstet Gynecol Reprod Biol 1981;12: 143-50.
39. Faxelius G, Bremme K, Christensen KK, Christensen P, Ringertz S. Neonatal septicemia due to group B streptococci: perinatal risk factors and outcome of subsequent pregnancies. J Perinat Med 1988; 16:423-30.
40. Taylor MC, Mercer BM, Engelhardt KF, Fricke JL. Patient preference for self-collected cultures for group B streptococcus is pregnancy. J Midwifery Wom Health 1997;42:410-3.
41. Mercer BM, Ramsey RD, Sibai BM. Prenatal screening for group B streptococcus. II. Impact of antepartum screening and prophylaxis on neonatal care. Am J Obstet Gynecol 1995;173:842-6.
42. Fargason CA, Peralta-Carcelen M, Rouse DJ, Cutter GR, Goldenberg RL. The pediatric costs of strategies minimizing the risk of early-onset group B streptococcal disease. Obstet Gynecol 1997;90:347-52.
43. Mohle-Boetani JC, Lieu TA, Ray GT, Escobar G for the Neonatal GBS Prevention Working Group. Pediatrics 1999;103:703-10.
44. Leftowitz RJ, Willerson JT. Incidence of congenital heart disease [letter]. J Am Med Assoc 2001;285:581-7.
45. Levine EM, Ghai V, Barton JJ, Strom CM. Intrapartum antibiotic prophylaxis increases the incidence of gram-negative neonatal sepsis. Infect Dis Obstet Gynecol 1999;7:210-3.
46. Baltimore RS, Huie SM, Meek JI, Schuchat A, O'Brien KL. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 2001;108:1094-8.
47. Joseph TA, Pyati SP, Jacons N. Neonatal early-onset Escherichia coli disease: The effect of intrapartum ampicillin. Arch Pediatr Adolesc Med 1998;152:35-40.
48. Towers CV, Carr MH, Padilla G, Asrat T. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol 1998;179: 879-83.
49. Eschenbach DA. Prevention of neonatal group B streptococcal infection [letter]. N Engl J Med 2002;347:280-1.
50. Gotoff SP, Boyer KM. Prevention of early-onset neonatal group B streptococcal disease. Pediatrics 1997;99:866-9.
51. Rouse DJ, Goldenberg RL, Cliver SP, Cutter GR, Mennemeyer ST, Fargason CA. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol 1994;83:483-94.
52. Yancey MK, Duff P, Kubilis P, Clark P, Frentzen BH. Risk factors for neonatal sepsis. Obstet Gynecol 1996;87:188-94.
53. Yancey MK, Armer T, Clark P, Duff P. Assessment of rapid identification tests for genital carriage of group B streptococci. Obstet Gynecol 1992;80:1038-47.
54. Greenspoon JS, Fishman A, Wilcox JG, Greenspoon RL, Lewis W. Comparison of culture for group B streptococcus versus enzyme immunoassay and latex agglutination tests: Results in 250 patients during labor. Obstet Gynecol 1991;77:97-100.
55. Philipson EH, Palermino DA, Robinson A. Enhanced antenatal detection of group B streptococcus colonization. Obstet Gynecol 1995;85: 437-9.
56. Baker CJ. Inadequacy of rapid immunoassays for intrapartum detection of group B streptococcal carriers. Obstet Gynecol 1996;88:51-5.
57. American College of Nurse-Midwives. Risks of devices for direct detection of group B streptococcal antigen. J Midwifery Wom Health 1997;42:408-9.
58. Samadi R, Stek A, Greenspoon JS. Evaluation of a rapid optical immunoassay-based test for group B streptococcus colonization in intrapartum patients. J Matern Fetal Med 2001;10:203-8.
59. Bergeron MG, Ke D, Menard C, Picard FJ, Gagnon M, Bernier M, et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med 2000;343:175-9.
60. Cochi SL, Feldman RA. Estimating national incidence of group B streptococcal disease: the effect of adjusting for birth weight [letter]. Pediatr Infect Dis 1983;2:414-5.